The Effect of Transforming Growth Factor- on Expression of MMP 2 and MMP 9 Cell Lines |
Kwon Nam-Young
(Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine)
Kim Hyung-Jin (Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine) Woo Jeong-Su (Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine) Kwon Soon-Young (Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine) Jung Kwang-Yoon (Department of Otolaryngology-Head and Neck Surgery, Korea University, College of Medicine) |
1 | Herron GS, Werb Z, Dwyer K, Banda MJ : Secretion of metallo-proteinases by stimulated capiilary endothelial cells. 1 : Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 1986 ; 261 : 2810-2813 PUBMED |
2 | Stetler-Stevenson WG, Hewitt R, Corcoran M : Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Sem in Cancer Biol 1996 ; 7 : 147-154 DOI ScienceOn |
3 | Tang B, Bottinger EP, Jakowlew S : Transforming growth factor 1 is a new form of tumor suppressor with haploid insufficiency. Nat Med 1998 ; 4 : 802-807 DOI ScienceOn |
4 | Adler RR, Brenner CA : Expression of extracellular matrix-degrading metalloproteinases and metalloproteinases inhibitors is developmentally regulated during endoderm differentiation of embryonal carcinoma cells. Development 1990 ; 110 : 221-220 |
5 | Massague J : TGF- signal transduction. Annu Rev Biochem 1998 ; 67 : 753-791 DOI PUBMED ScienceOn |
6 | Ranuncolo SM, Matos E : Circulating 92kDa matrix metallo-proteinase (MMP 9) activity is enhanced in the euglobulin plasma fractior head and neck squamous cell carcinoma. Cancer 2002 ; 94 : 1483-1491 DOI ScienceOn |
7 | Takaku K, Oshima M, Miyoshi H : Intestinal tumorigenesis in compound mutant mice of both Smad4 and APC genes. Cell 1998 ; 92 : 645-656 DOI ScienceOn |
8 | Pashe B : Role of Transforming Growth Factor in cancer. J Cell Phys 2001 ; 186 : 153-168 DOI PUBMED ScienceOn |
9 | Wrana JL, Attisano L, Wieser R, Ventura F : Mechanism of activation of TGF- receptor, Nature 1994 ; 370 : 341-347 |
10 | Kleiner DE, Stetler-Stevenson WG : Quantitative zymography : detection of picogram quantities of gelatinase. Anal Biochem 1994 ; 218 : 325-329 DOI ScienceOn |
11 | Sarioglu S, Pabuccuoglu U : Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 2001 ; 197 : 483-486 DOI ScienceOn |
12 | Blobe GC, Shiemann WP, Lodish HF : Role of transforming growth factor in human disease. N Engl J Med 2000 ; 342 : 1350-1358 DOI PUBMED ScienceOn |
13 | Lee BI, Park SH, Kim JH : MS-275, a histone deacetylase inhibitor selectively induces transforming growth factor type Ⅱ receptor exression in human breast cancer cells. Cancer Res 2001 ; 61 ; 931-934 |
14 | Davies B, Miles DW, Balkwill FR : Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993 ; 67 : 1126-1131 DOI PUBMED ScienceOn |
15 | DiLorenzo TP, Steinberg BM : Laryngeal keratinocytes show variable inhibition of replication by TGF-beta. J Cell Sci 1990 ; 96 : 115-119 PUBMED |
16 | Garbett EA, Reed MWT, Brown NJ : Proteolysis in human cancer. Br J Cancer 1999 ; 81 : 287-293 DOI ScienceOn |
17 | Malkowitz S, Wang J, Myeroff L : Inactivation of the type Ⅱ TGF- receptor in colon cancer cells with microsatellite instability. Science 1995 ; 268 ; 1336-1338 |
18 | Hagedorn H, Nerlich A : Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas. Anticancer Res 1999 ; 19 : 4265-4272 PUBMED |
19 | De Caestecke MP, Roberts P : Role of Transforming Growth Factor- signaling in cancer. J Nat Cancer Inst 2000 ; 92 : 1338-1402 |
20 | Stetler-Stevenson WG : Progelatinase A activation during tumor cell invasion. Invasion Metastasis 1994 ; 14 : 41-48 |